Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,838,755 | 5,906,221 | 5,791,947 | 5,635,655 | 5,187,168 |
| Depreciation Amortization | 848,584 | 600,133 | 483,346 | 474,480 | 440,299 |
| Accounts receivable | -318,687 | -400,751 | 10,481 | -705,701 | -363,667 |
| Accounts payable and accrued liabilities | -59,660 | 175,223 | -60,912 | 161,082 | -3,422 |
| Other Working Capital | 364,257 | 313,292 | -169,520 | 53,347 | -263,525 |
| Other Operating Activity | 339,374 | 227,669 | 198,077 | 1,560,597 | 700,252 |
| Operating Cash Flow | $7,012,622 | $6,821,787 | $6,253,419 | $7,179,460 | $5,697,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 305,167 | 306,710 | 223,200 |
| PPE Investments | -1,338,307 | -1,471,357 | -1,157,022 | -1,049,265 | -775,099 |
| Net Acquisitions | -450 | 56,267 | N/A | N/A | 342,686 |
| Purchase Of Investment | -67,005 | -37,919 | -6,076 | -75,489 | -527,050 |
| Sale Of Investment | 22,185 | 27,216 | 11,089 | -16,643 | 4,762 |
| Purchase Sale Intangibles | -344,620 | -424,145 | -155,242 | -178,171 | -175,882 |
| Other Investing Activity | -341,622 | -421,239 | -151,293 | -174,307 | -175,882 |
| Investing Cash Flow | $-1,725,199 | $-1,847,032 | $-998,135 | $-1,008,994 | $-907,382 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -111,076 | 14,373 | N/A | N/A | N/A |
| Common Stock Repurchased | -2,298,567 | -2,380,194 | -2,558,756 | -2,237,470 | -2,558,765 |
| Dividend Paid | -2,909,409 | -2,912,439 | -2,862,404 | -3,541,138 | -1,920,264 |
| Other Financing Activity | 0 | -1 | 1 | 0 | 0 |
| Financing Cash Flow | $-5,319,052 | $-5,278,261 | $-5,421,159 | $-5,778,608 | $-4,479,029 |
| Exchange Rate Effect | -1,049 | 6,728 | -32,051 | -3,864 | 12,797 |
| Beginning Cash Position | 2,342,787 | 2,623,458 | 2,804,226 | 2,355,310 | 2,034,989 |
| End Cash Position | 2,310,109 | 2,389,674 | 2,606,300 | 2,743,305 | 2,358,480 |
| Net Cash Flow | $-32,678 | $-233,784 | $-197,926 | $387,995 | $323,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,012,622 | 6,821,787 | 6,253,419 | 7,179,460 | 5,697,105 |
| Capital Expenditure | -1,338,907 | -1,473,344 | -1,158,389 | -1,050,305 | -777,331 |
| Free Cash Flow | 5,673,715 | 5,348,443 | 5,095,030 | 6,129,155 | 4,919,774 |